RaySearch Laboratories AB (STO:RAYB) has entered into an exclusive distribution agreement with AlphaXRT (formerly CMS Alphatech) based in Sydney, Australia and Auckland, New Zealand. The agreement means that AlphaXRT will be fully responsible for marketing, sales and service of RaySearch's proprietary treatment planning system RayStation® in Australia and New Zealand from April 1, 2014.
Australasia is a well-established, world renowned and growing radiation therapy market. AlphaXRT is a leading distributor of software and equipment used in the treatment of cancer and represents a wide range of respected international suppliers. The company was founded in 1990 and the dedicated sales and support team at AlphaXRT are highly experienced in the field of radiation therapy treatment planning systems and serve all radiation therapy centres in Australia and New Zealand.
"AlphaXRT is delighted to be representing RaySearch Laboratories in the treatment planning market in Australasia. RaySearch have a longstanding reputation in treatment planning solutions and RayStation® is the leading independent treatment planning system available. We look forward to working with RaySearch to promote RayStation® to our customers in the region", says Richard Neale, Managing Director of AlphaXRT.
"AlphaXRT is a leading distributor of advanced radiation therapy equipment with a long track record, so we are of course delighted that they have elected to partner with RaySearch. We will now work closely together with AlphaXRT's experienced experts to satisfy the needs of existing and future RayStation® customers and I am fully convinced that this collaboration will be highly fruitful for both companies", says Johan Löf, CEO of RaySearch.
Long-term prostate cancer treatment study informs decisions for diverse groups